You get what you agree to, at least when it comes to the money under VPAS Rising payment percentages under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) have been criticised despite Share X You get what you agree to, at least when it comes to the money under VPAS https://pharmaphorum.com/views-and-analysis/you-get-what-you-agree-to-at-least-when-it-comes-to-vpas/
The language of leadership Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional, and global life Share X The language of leadership https://pharmaphorum.com/sales-marketing/the-language-of-leadership/
Unlocking the full power of data for Pharma The value of data has never been greater in healthcare. With greater digital engagement and opportunities available as Share X Unlocking the full power of data for Pharma https://pharmaphorum.com/sales-marketing/unlocking-the-full-power-of-data-for-pharma/
Achieving commercial excellence with data-driven decisions Executing an effective commercial success strategy requires extensive planning and implementation within pharmaceutical companies that spans teams, functions, Share X Achieving commercial excellence with data-driven decisions https://pharmaphorum.com/views-and-analysis/achieving-commercial-excellence-with-data-driven-decisions/
Every scientific message has a story. Medical communications must adapt to effectively bring these to life. Medical communications are in a state of transition. Due to the combined impact of emerging technologies, changing provider Share X Every scientific message has a story. Medical communications must adapt to effectively bring these to life. https://pharmaphorum.com/sales-marketing/every-scientific-message-has-a-story-medical-communications-must-adapt-to-effectively-bring-these-to-life/
Amplifying HCP engagement using modular content Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the most significant wave Share X Amplifying HCP engagement using modular content https://pharmaphorum.com/views-and-analysis/amplifying-hcp-engagement-using-modular-content/
Company Profile: Viseven There is no doubt that pharma has developed quite a bit regarding its digital maturity. That said, there Share X Company Profile: Viseven https://pharmaphorum.com/sales-marketing/company-profile-viseven/
Gene therapies for prevalent diseases in Europe – the perfect storm of economic sustainability? In this article, Research Partnership reviews why the path to commercialisation for the half a dozen approvals in Share X Gene therapies for prevalent diseases in Europe – the perfect storm of economic sustainability? https://pharmaphorum.com/sales-marketing/gene-therapies-for-prevalent-diseases-in-europe-the-perfect-storm-of-economic-sustainability/
The doctors have spoken: what physicians need from pharma comms in the post-pandemic world In the rapidly changing field of medicine, effective communications are essential to ensuring that innovations are cascaded out Share X The doctors have spoken: what physicians need from pharma comms in the post-pandemic world https://pharmaphorum.com/sales-marketing/the-doctors-have-spoken-what-physicians-need-from-pharma-comms-in-the-post-pandemic-world/
